Rankings
▼
Calendar
RGEN Q1 2018 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena
RGEN
Repligen Corporation
$7B
Q1 2018 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$45M
+46.6% YoY
Gross Profit
$25M
56.1% margin
Operating Income
$6M
13.3% margin
Net Income
$3M
7.7% margin
EPS (Diluted)
$0.08
QoQ Revenue Growth
+7.7%
Cash Flow
Operating Cash Flow
$2M
Free Cash Flow
$8,000
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$743M
Total Liabilities
$146M
Stockholders' Equity
$597M
Cash & Equivalents
$174M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$45M
$31M
+46.6%
Gross Profit
$25M
$17M
+51.6%
Operating Income
$6M
$6M
+5.3%
Net Income
$3M
$3M
+12.4%
Geographic Segments
North America
$20M
45%
Europe
$19M
43%
Asia Pacific
$5M
11%
All Other
$243,000
1%
← FY 2018
All Quarters
Q2 2018 →